This article needs additional citations for verification. Please help improve this articlebyadding citations to reliable sources. Unsourced material may be challenged and removed.
Find sources: "Chattem" – news · newspapers · books · scholar · JSTOR (April 2007) (Learn how and when to remove this message) |
Chattem, Inc. is an American, Chattanooga, Tennessee-based, producer and marketer of over-the-counter healthcare products, toiletries, dietary supplements, topical analgesics, and medicated skin care products. Originally named the Chattanooga Medicine Company, the company’s brand portfolio holds twenty-two brands including Allegra, Gold Bond, Flexall, IcyHot, Rolaids, Sun-In, Pamprin, Dexatrim, Aspercreme, and Selsun Blue. The company produces two-thirds of its products at its Chattanooga production facilities with the remaining produced by third-party producers. The company is a subsidiary of the French multinational pharmaceutical company Sanofi.
 | |
| Company type | Subsidiary |
|---|---|
| Industry | healthcare Over-the-counter-drug manufacturing |
| Founded | Tennessee (January 30, 1879, as the Chattanooga Medicine Company) |
| Headquarters |
Chattanooga, Tennessee
|
Key people | Zan Guerry, Chairman, Shaquille O'Neal, brand spokesman, IcyHot and Gold Bond |
| Products | Allegra, Gold Bond, ACT Mouthwash, Cortizone-10, Flexall, IcyHot, Sun-In, Ultra Swim, Pamprin, Premsyn, Kaopectate, Dexatrim, Aspercreme, Selsun Blue, Nasacort, Unisom, Capzasin, Benzodent, Herpecin-L, Garlique, and New Phase |
| Revenue | $1 Billion (USD) (2013) |
Number of employees | 536[1] |
| Parent | Sanofi |
| Website | Chattem.com |
The company’s brands are sold nationally through mass merchandiser, drug and food retailers. In 2005, 70% of the firm's sales were made through its top ten customers, which include Wal-Mart, Walgreens, and Kroger. Sales to Wal-Mart constituted 36% of Chattem’s total sales in 2005. Chattem supports these sales with a forty-five-person sales force and broadcast media advertising. Chattem has market penetration in the United States, Europe, Canada, Latin America, and the Caribbean.
In October 2006, Chattem announced it would acquire five brands for $410 million as a result of the merger between Johnson & Johnson and the consumer healthcare business of Pfizer. These brands are:
Pending the US government’s approval of the merger of Johnson & Johnson and Pfizer Consumer Healthcare, Chattem will acquire five brands divested from the firms. Chattem has announced it expects to take possession of the brands around January 2007. These mature brands will provide $150 million in additional revenue to Chattem per year.[citation needed]
On December 21, 2009, Paris-based (France) Sanofi, the world's fourth largest drugmaker, said it was acquiring Chattem in a $1.9 billion cash deal. Sanofi said the acquisition would be completed by the first quarter of 2010.[6]
Chattem manufactures many over-the-counter healthcare products. They are marketed in three categories: pain relief, skin & hair care, and health & wellness.
{{cite web}}: CS1 maint: archived copy as title (link)